SkyQuest Technology Group recently introduced MicroRNA Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The MicroRNA Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Global MicroRNA Market size was valued at USD 1.35 billion in 2023 and is poised to grow from USD 1.52 billion in 2024 to USD 4.02 billion by 2032, growing at a CAGR of 12.9% during the forecast period (2025-2032).
According to the estimates from the American Cancer Society, 609,360 deaths from cancer were registered in 2022 alone in the US, and over 1.9 million people were newly diagnosed with cancer. In addition, the pace at which microRNA diagnostics gained ground in clinical settings brought forward developments in precision medicine of cancer. As per the microRNA market analysis, the two key factors driving the growth of the market include growing prevalence of such diseases as cancer, heart disease, and other neurological conditions worldwide and rapid developments in genomic technologies.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/microrna-market
The 2025 global MicroRNA Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the MicroRNA Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The MicroRNA Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global MicroRNA Market is segmented by Products, Services, Application, End-use and region.
Based on Products, the market is segmented into Instruments and Consumables.
Based on Services, the market is segmented into Type and Specimen.
Based on Application, the market is segmented into Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Others.
Based on End-use, the market is segmented into Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Others.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
MicroRNA Market – Regional Analysis:
The microRNA market outlook highlighted that in 2023, the market was dominated by North America. This is so because growth in the region of microRNA is attributed to a number of factors, such as availability of significant population of major players in the area; some of which are Merck KGaA., NanoString Technologies, Inc.
Asia-Pacific will be growing at the fastest rate over the projection period. Key players in the region will be energized by growth opportunities due to factors such as the presence of a humongous target population, faster uptake of a range of technologies, presence of a multitude of start-ups along with an emergent healthcare infrastructure, and high unmet clinical needs. In 2023, the country, China, within Asia-Pacific accounted for the largest microRNA market share. The growing importance of precision medicine and the huge potential of miRNAs in this regard are anticipated to drive the microRNA industry growth forward.
Top Market Players in MicroRNA Market are:
Thermo Fisher Scientific (US)
QIAGEN (Germany)
Illumina (US)
Takara Bio (Japan)
New England Biolabs (UK)
NanoString Technologies (US)
Merck KGaA (Germany)
Horizon Discovery (UK)
GeneCopoeia (US)
Bio-Rad Laboratories (US)
LGC Limited (UK)
BioGenex (US)
PerkinElmer (US)
Agilent Technologies (US)
Roche Holding AG (Switzerland)
System Biosciences (US)
MiRXES (Singapore)
aceRNA Technologies (Japan)
ARTHEx Biotech (Spain)
For a customized report, contact us to request personalization – https://www.skyquestt.com/speak-with-analyst/microrna-market
Recent Developments in MicroRNA Market:
Thermo Fisher Scientific plans to spend USD 3.1 billion for October 2023 acquisition of Olink Holding AB towards expanding the portfolio of life sciences offerings supporting drug discovery.
With an investigation of microRNAs (miRNAs), the group of scientists at the University of Illinois Urbana was able to develop a new point-of-care cancer diagnosis test with high success rate in February 2022. A recently developed assay makes use of nanoparticles that capture tumor-specific miRNAs from human serum, offering an efficient method for potentially providing an attractive strategy for rapid and accurate cancer screening at the point of service..
Biotechnology firm MiRXES has just unveiled multiple innovation upgrades that it hopes will bolster its research and manufacturing capacity on the miRNA-based testing for illness detection. Among these innovations is the launch of a cooperative multi-cancer screening research project, building of an Industry 4.0 (i4.0) production facility and installment of two cutting-edge labs. The recent launches were announced by MiRXES, a company based in Singapore, late in August 2022.
Take Action Now: Secure Your MicroRNA Market Today – https://www.skyquestt.com/buy-now/microrna-market
Forward-Looking Insights
The MicroRNA Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
